4//SEC Filing
Liatos John 4
Accession 0001213900-20-023272
CIK 0001498382other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:17 PM ET
Size
5.3 KB
Accession
0001213900-20-023272
Insider Transaction Report
Form 4
Liatos John
DirectorSVP, Business Development
Transactions
- Purchase
Common Stock
2020-08-19+196,750→ 196,750 total
Footnotes (1)
- [F1]Received in exchange for 125,000 shares of Adgero Biopharmaceuticals Holdings, Inc. ("Adgero") common stock, par value $0.0001 per share, in connection with the completion of the merger (the "Merger"), on August 19, 2020 (the "Effective Date"), of Adgero Acquisition Corp., a subsidiary of the Issuer, with and into Adgero, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 9, 2020. On the Effective Date, each share of Adgero common stock was converted automatically into the right to receive 1.5740 shares of the Issuer's common stock, par value $0.001 per share.
Documents
Issuer
Kintara Therapeutics, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001821508
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 4:17 PM ET
- Size
- 5.3 KB